SS Innovations has accomplished a historic feat by completing Indonesia’s initial robotic cardiac surgery using its advanced surgical robot platform. Based in Fort Lauderdale, Florida, the company is known for developing the Mantra series of surgical robots, with the latest iteration being the Mantra 3, launched earlier in the year. The company has also begun regulatory approval processes in the U.S. and Europe, anticipating approval in late 2025.
Mantra 3 offers versatility for various specialties, including cardiothoracic, head and neck, gynecology, urology, and general surgeries. At Jakarta’s Harapan Kita National Cardiac Hospital, doctors performed significant procedures such as a bilateral IMA coronary artery bypass graft, ASD repair, and a beating heart totally endoscopic coronary artery bypass (TECAB). According to the company, this success in Indonesia represents a groundbreaking advancement for both the nation and its innovative surgical robot. Dr. Sudhir Srivastava, the founder, chair, and CEO of SS Innovations, spearheaded the TECAB procedure.
The organization believes this introduction of robotic cardiac surgery in Indonesia heralds a transformative phase for cardiac care in the country. Following the pioneering TECAB surgery, additional procedures were successfully conducted by SS Innovations and Harapan Kita’s surgical team in subsequent days.
Dr. Srivastava remarked, “Achieving this milestone with the SSi Mantra underscores our commitment to revolutionizing surgical practice, enhancing accessibility, and promoting the global adoption of affordable robotic surgery.” He added that this partnership specifically addresses the pressing demand for safe, timely, and economically viable cardiac care, offering patients less invasive treatment options and improved quality of life. The successful application of the SSi Mantra in cardiac surgery sets the stage for the company to build momentum, capture market share in pivotal regions, and further pursue its mission to provide affordable robotic surgery to patients worldwide.”